Waleed H. Hassanein - Aug 21, 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
President & CEO, Director
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Aug 21, 2024
Transactions value $
-$7,072,100
Form type
4
Date filed
8/23/2024, 04:30 PM
Previous filing
Aug 19, 2024
Next filing
Sep 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $320K +20K +32.44% $16.00 81.6K Aug 21, 2024 Direct
transaction TMDX Common Stock Sale -$3.42M -20K -24.5% $171.03 61.6K Aug 21, 2024 Direct F1
transaction TMDX Common Stock Options Exercise $404K +25K +40.56% $16.14 86.6K Aug 22, 2024 Direct
transaction TMDX Common Stock Sale -$4.38M -25K -28.85% $175.00 61.6K Aug 22, 2024 Direct
holding TMDX Common Stock 469K Aug 21, 2024 By the Waleed H. Hassanein Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -20K -7% $0.00 266K Aug 21, 2024 Common Stock 20K $16.00 Direct F2
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -25K -14.04% $0.00 153K Aug 22, 2024 Common Stock 25K $16.14 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $171.00 to $171.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The option is fully vested.
F3 The option is fully vested.